Premier Alternatives

Turbine (Drug Discovery)

London, United Kingdom · Founded 2015 · Privately Held (backing)

Developer of cancer combination therapies designed to clarify the underlying biology of diseases and develop personalized therapies. Turbine (Drug Discovery) is based in London, United Kingdom and was founded in 2015. Its last reported valuation was $90.2 million in Nov 2025. It has raised $64.4 million.

Last reported valuation
$90.2M
Oct 2026
Priced at
—
Total raised
$64.4M
Last round
—

Turbine (Drug Discovery) key facts

as of Oct 2026
  • Developer of cancer combination therapies designed to clarify the underlying biology of diseases and develop personalized therapies.
  • Turbine (Drug Discovery) is valued at approximately $90.2M as of Oct 2026 (last reported valuation).
  • It has raised $64.4M; the latest was Later Stage VC ($26.3M) in Nov 2025.
  • Notable investors include Accel, AWS Startups, Mercia Ventures, MassMutual Ventures, Crane Venture Partners — 24 tracked in total.
  • Status: Privately Held (backing).
Last reported valuation
LOW confidence
$90.2M

Turbine (Drug Discovery)'s last reported valuation, Nov 2025. Nothing priced has surfaced since.

set by last reported valuationas of Oct 2026question about this number?
Free account
More of Turbine (Drug Discovery) with a free account
  • ·The complete investor list: 24 names
  • ·Watch Turbine (Drug Discovery): the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Turbine (Drug Discovery) funding rounds

No rounds on record

No funding rounds for Turbine (Drug Discovery) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

Turbine (Drug Discovery) valuation

Turbine (Drug Discovery)'s last reported valuation was $90.2 million in Nov 2025. No priced round, secondary trade or fund mark has surfaced since.

Turbine (Drug Discovery) investors

24 investors are on record for Turbine (Drug Discovery), including Accel, AWS Startups, Mercia Ventures and MassMutual Ventures. By type, the record holds 6 venture capital firms.

About Turbine (Drug Discovery)

Developer of cancer combination therapies designed to clarify the underlying biology of diseases and develop personalized therapies. The company's combination therapies leverage bioinformatics, network medicine, and artificial intelligence to reliably simulate complex interventions by screening millions of possible drug combinations on simulated cells, enabling cancer patients to receive a low-cost and effective cancer treatment plan.

Sector
Healthcare
HQ
London, United Kingdom
Founded
2015
Employees
104
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.